Skip to main content
. 2020 Apr 9;50(2):324–329. doi: 10.3906/sag-1904-167

Table 2.

Comparison of serum midkine levels and other inflammation markers between Crohn’s patients and controls.

Control group(n: 36) Activation ofCrohn’s (n: 37) Remission ofCrohn’s (n: 28) P
WBC (/mm3 × 103) 6.5 ± 1.1 9 ± 3.6 7.7 ± 2.1 0.001*
Platelet (/mm3 × 103) 249 ± 62 272 ± 84 284 ± 74 0.172
CRP (mg/L) 0.3 (0.3–6.5) 1.24 (0.1–12) 0.3 (0.1–4) <0.001**
ESR (mm/h) 8 (2–36) 21 (2–56) 13 (2–45) 0.065
Midkine 154.8 ± 76.1 281 ± 109.7 270.8 ± 90.8 <0.001***

Data are presented as median (range) or mean ± SD. *Active vs. remission, P = 0.049; active vs. control, P < 0.001; remission vs. control, P = NS. **Active vs. remission and control, P < 0.001; remission vs. control, P = 0.502. ***Control vs. active and remission, P < 0.001, active vs. remission, P = 0.666.